The Bethesda system and evaluation of abnormal Pap smears

Seminars in Surgical Oncology

Volumn 16, Issue 3, 1999, Pages 217-221

  Nguyen, Hoa N ^a   Nordqvist, Staffan R B ^a  

^a Sheridan Health Care Corporation   (United States)

Author keywords

Age factors; Biopsy; Cervical dysplasia; Cervical intraepithelial neoplasia; Cervix neoplasms; Cervix uteri; Colposcopy; False negative reactions; False positive reactions; Human papillomavirus; Incidence; Neoplasm staging; Pre cancerous conditions; Predictive value of tests; Risk factors; Sensitivity and specificity; Squamous cell carcinoma; Tumor virus infections; Vaginal smears

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLPOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; PAPANICOLAOU TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WART VIRUS;

FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032919377     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199904/05)16:3<217::AID-SSU4>3.0.CO;2-U     Document Type: Article

References (21)

1. National Institute of Health Consensus Conference on Cervical Cancer. Bethesda, Maryland, April 1-3, 1996. [Review]. J Natl Cancer Inst Monogr 1996;21:1-148.
2. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA 1999;49(1):8-31.
3. Kurman RJ, Henson DE, Herbst AL, et al: Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-1869.
4. Kost ER, Snyder RR, Schwartz LE, Hankins GD: The "less than optimal" cytology: importance in obstetric patients and in a routine gynecologic population. Obstet Gynecol 1993;81:127-130.
5. Widra EA, Dookhan D, Jordan A, et al: Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda System. J Reprod Med 1994;39:682-684.
6. Moritz FJ, Monk BJ, Fowler JM, Nguyen L: Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;89(3 Pt 1):385-388.
7. Slawson DC, Bennett JH, Simon LJ, Herman JM: Should all women with cervical atypia be referred for colposcopy: a HARNET study. J Fam Prac 1994;38:387-392.
8. Taylor RR, Guerrieri JP, Nash JD, et al: Atypical cervical cytology. Colposcopic follow-up using the Bethesda system. J Reprod Med 1993;38:443-447.
9. Kaufman RH: Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion: diagnostic criteria and management. Am J Obstet Gynecol 1998;175(4 Pt 2):1120-1128.
10. Wright TC, Kurman RJ: A critical review of the morphologic classification systems of pre-invasive lesion of the cervix. The scientific basis for shifting the paradigm. Papillomavirus Rep 1994:5:175-182.
11. Wright TC, Sum XW, Koulos J: Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-210.
12. Flannelly G, Anderson D, Kitchener HC, et al: The management of women with mild and moderate cervical dyskaryosis. BMJ 1994;308(6941):1399-1403.
13. Higgins RV, Hall JB, McGee A, et al: Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear. Obstet Gynecol 1994;84:174-178.
14. Isacson C, Kurman RJ: The Bethesda system: a new classification for managing Pap smears. Contemp Ob/Gyn 1995;6:67-72.
15. Korn AP: Interpretation of abnormal Pap smears. Infect Med 1996;13:405-411.
16. Kennedy AW, Saimieri SS, Wirth SL, et al: Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1998;63:14-18.
17. Appleby J: Management of the abnormal Papanicolaou smear [Review]. Med Clin North Am 1995;79:345-360.
18. Ferenczy A, Robitaille J, Franco E, et al: Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology. Acta Cytol 1996;40:1136-1142.
19. Sherman ME, Schiffman MH, Mango LJ, et al: Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear. Mod Pathol 1997;10:564-571.
20. Ferris DG, Wright TC Jr, Litaker MS, et al: Triage of women with ASCUS and LGSIL on Pap smear reports: management by repeat pap smear, HPV DNA testing, or colposcopy? J Fam Pract 1998;46:125-134.
21. Richart RM, Wright TC, Jr.: Controversies in the management of low-grade cervical intraepithelial neoplasia [Review]. Cancer 1993;71:1413-1421.